Journal article
CTHRC1 promotes angiogenesis by recruiting Tie2-expressing monocytes to pancreatic tumors
Experimental & molecular medicine, Vol.48(9), pp.e261-e261
09/01/2016
DOI: 10.1038/emm.2016.87
PMCID: PMC5050301
PMID: 27686285
Abstract
CTHRC1 (collagen triple-helix repeat-containing 1), a protein secreted during the tissue-repair process, is highly expressed in several malignant tumors, including pancreatic cancer. We recently showed that CTHRC1 has an important role in the progression and metastasis of pancreatic cancer. Although CTHRC1 secretion affects tumor cells, how it promotes tumorigenesis in the context of the microenvironment is largely unknown. Here we identified a novel role of CTHRC1 as a potent endothelial activator that promotes angiogenesis by recruiting bone marrow-derived cells to the tumor microenvironment during tumorigenesis. Recombinant CTHRC1 (rCTHRC1) enhanced endothelial cell (EC) proliferation, migration and capillary-like tube formation, which was consistent with the observed increases in neovascularization in vivo. Moreover, rCTHRC1 upregulated angiopoietin-2 (Ang-2), a Tie2 receptor ligand, through ERK-dependent activation of AP-1 in ECs, resulting in recruitment of Tie2-expressing monocytes (TEMs) to CTHRC1-overexpressing tumor tissues. Treatment with a CTHRC1-neutralizing antibody-abrogated Ang-2 expression in the ECs in vitro. Moreover, administration of a CTHRC1-neutralizing antibody to a xenograft mouse model reduced the tumor burden and infiltration of TEMs in the tumor tissues, indicating that blocking the CTHRC1/Ang-2/TEM axis during angiogenesis inhibits tumorigenesis. Collectively, our findings support the hypothesis that CTHRC1 induction of the Ang-2/Tie2 axis mediates the recruitment of TEMs, which are important for tumorigenesis and can be targeted to achieve effective antitumor responses in pancreatic cancers.
Details
- Title: Subtitle
- CTHRC1 promotes angiogenesis by recruiting Tie2-expressing monocytes to pancreatic tumors
- Creators
- Jaemin Lee - Korea Research Institute of Bioscience and BiotechnologyJinhoi Song - Korea Research Institute of Bioscience and BiotechnologyEun-Soo Kwon - Korea Research Institute of Bioscience and BiotechnologySeongyea Jo - Korea Research Institute of Bioscience and BiotechnologyMin Kyung Kang - Dong-A UniversityYeon Jeong Kim - Department of Biological Sciences, Dong-A UniversityYeonsil Hwang - Korea Advanced Institute of Science and TechnologyHosung Bae - Korea Advanced Institute of Science and TechnologyTae Heung Kang - Konkuk UniversitySuhwan Chang - Asan Medical CenterHee Jun Cho - Korea Research Institute of Bioscience and BiotechnologySong Cheol Kim - Asan Medical CenterSeokho Kim - Korea Research Institute of Bioscience and BiotechnologySang Seok Koh - Dong-A University
- Resource Type
- Journal article
- Publication Details
- Experimental & molecular medicine, Vol.48(9), pp.e261-e261
- DOI
- 10.1038/emm.2016.87
- PMID
- 27686285
- PMCID
- PMC5050301
- NLM abbreviation
- Exp Mol Med
- ISSN
- 1226-3613
- eISSN
- 2092-6413
- Publisher
- Nature Publishing Group
- Alternative title
- CTHRC1 recruits Tie-2-expressing monocytes to pancreatic tumors
- Language
- English
- Date published
- 09/01/2016
- Academic Unit
- Internal Medicine
- Record Identifier
- 9985217131402771
Metrics
6 Record Views